Sirolimus-eluting stent superior for coronary artery restenosis prevention

Author：

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1389, 2003-01, pp. : 13-14

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

A polymer-free, sirolimus-eluting stent is as effective as a standard, polymer-based, paclitaxel-eluting stent in the prevention of coronary artery restenosis

Inpharma, Vol. 1, Iss. 1530, 2006-01 ,pp. : 15-15

Adis International

Access to resources Recommend Favorite

Sirolimus-eluting stent superior to balloon angioplasty in restenosis

Inpharma, Vol. 1, Iss. 1544, 2006-01 ,pp. : 16-16

Adis International

Access to resources Recommend Favorite

Sirolimus-eluting stent reduces restenosis, coronary events

Inpharma, Vol. 1, Iss. 1342, 2002-01 ,pp. : 12-12

Adis International

Access to resources Recommend Favorite

Spotlight on the Sirolimus-Eluting Stent in Coronary Artery Disease

By McKeage K. Murdoch D. Goa K.L.

American Journal of Drug Delivery, Vol. 2, Iss. 1, 2004-01 ,pp. : 69-73

Adis International

Access to resources Recommend Favorite

Sirolimus-eluting stents are more effective than bare stents for the prevention of coronary artery restenosis in patients with de novo lesions

Inpharma, Vol. 1, Iss. 1426, 2004-01 ,pp. : 12-12

Adis International

Access to resources Recommend Favorite